APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lyophilized IVIG

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Lyophilized IVIG Industry Growth and Trends Forecast to 2032

22 December 2025107 pages

Choose your research edition.

Industry ResearchLyophilized IVIG Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Lyophilized IVIG Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Lyophilized IVIG Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lyophilized IVIG Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Lyophilized IVIG Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Lyophilized IVIG market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Lyophilized IVIG is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Lyophilized IVIG is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lyophilized IVIG is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Lyophilized IVIG include Biotest, BPL, CBPO, CNBG, CSL, Grifols, Kedrion, LFB Group and Octapharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Lyophilized IVIG market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Lyophilized IVIG market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Lyophilized IVIG market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Lyophilized IVIG.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Lyophilized IVIG market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Lyophilized IVIG Market by Company

Biotest

BPL

CBPO

CNBG

CSL

Grifols

Kedrion

LFB Group

Octapharma

Hualan Bio

Shanghai RAAS

Sichuan Yuanda Shuyang

Takeda

Lyophilized IVIG Segment by Type

2.5g

1.25g

Lyophilized IVIG Segment by Application

Autoimmune Disease

Immunodeficiency

Acute Infection

Lyophilized IVIG Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lyophilized IVIG market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lyophilized IVIG and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lyophilized IVIG.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Lyophilized IVIG manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Lyophilized IVIG in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 2.5g Table 2. Major Company of 1.25g Table 3. Global Lyophilized IVIG Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Lyophilized IVIG Sales by Type (2021-2026) & (k units) Table 5. Global Lyophilized IVIG Sales Market Share in Volume by Type (2021-2026) Table 6. Global Lyophilized IVIG Sales by Type (2021-2026) & (US$ Million) Table 7. Global Lyophilized IVIG Sales Market Share in Value by Type (2021-2026) Table 8. Global Lyophilized IVIG Price by Type (2021-2026) & (US$/unit) Table 9. Global Lyophilized IVIG Sales by Type (2027-2032) & (k units) Table 10. Global Lyophilized IVIG Sales Market Share in Volume by Type (2027-2032) Table 11. Global Lyophilized IVIG Sales by Type (2027-2032) & (US$ Million) Table 12. Global Lyophilized IVIG Sales Market Share in Value by Type (2027-2032) Table 13. Global Lyophilized IVIG Price by Type (2027-2032) & (US$/unit) Table 14. North America Lyophilized IVIG Sales by Type (2021-2026) & (k units) Table 15. North America Lyophilized IVIG Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Lyophilized IVIG Sales by Type (2021-2026) & (k units) Table 17. Europe Lyophilized IVIG Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Lyophilized IVIG Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Lyophilized IVIG Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Lyophilized IVIG Sales by Type (2021-2026) & (k units) Table 21. Latin America Lyophilized IVIG Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Lyophilized IVIG Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Lyophilized IVIG Sales by Type (2021-2026) & (US$ Million) Table 24. Lyophilized IVIG Industry Trends Table 25. Lyophilized IVIG Industry Drivers Table 26. Lyophilized IVIG Industry Opportunities and Challenges Table 27. Lyophilized IVIG Industry Restraints Table 28. Global Lyophilized IVIG Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Lyophilized IVIG Revenue Market Share by Company (2021-2026) Table 30. Global Lyophilized IVIG Sales by Company (2021-2026) & (k units) Table 31. Global Lyophilized IVIG Sales Share by Company (2021-2026) Table 32. Global Lyophilized IVIG Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Lyophilized IVIG Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Lyophilized IVIG Major Company Production Sites and Headquarters Table 35. Global Lyophilized IVIG Company, Product Type & Application Table 36. Global Lyophilized IVIG Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Lyophilized IVIG by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Lyophilized IVIG Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Lyophilized IVIG Sales by Region (2021-2026) & (k units) Table 41. Global Lyophilized IVIG Sales Market Share in Volume by Region (2021-2026) Table 42. Global Lyophilized IVIG Sales by Region (2021-2026) & (US$ Million) Table 43. Global Lyophilized IVIG Sales Market Share in Value by Region (2021-2026) Table 44. Global Lyophilized IVIG Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Lyophilized IVIG Sales by Region (2027-2032) & (k units) Table 46. Global Lyophilized IVIG Sales Market Share in Volume by Region (2027-2032) Table 47. Global Lyophilized IVIG Sales by Region (2027-2032) & (US$ Million) Table 48. Global Lyophilized IVIG Sales Market Share in Value by Region (2027-2032) Table 49. Global Lyophilized IVIG Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Lyophilized IVIG Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Lyophilized IVIG Sales by Application (2021-2026) & (k units) Table 52. Global Lyophilized IVIG Sales Market Share in Volume by Application (2021-2026) Table 53. Global Lyophilized IVIG Sales by Application (2021-2026) & (US$ Million) Table 54. Global Lyophilized IVIG Sales Market Share in Value by Application (2021-2026) Table 55. Global Lyophilized IVIG Price by Application (2021-2026) & (US$/unit) Table 56. Global Lyophilized IVIG Sales by Application (2027-2032) & (k units) Table 57. Global Lyophilized IVIG Sales Market Share in Volume by Application (2027-2032) Table 58. Global Lyophilized IVIG Sales by Application (2027-2032) & (US$ Million) Table 59. Global Lyophilized IVIG Sales Market Share in Value by Application (2027-2032) Table 60. Global Lyophilized IVIG Price by Application (2027-2032) & (US$/unit) Table 61. North America Lyophilized IVIG Sales by Application (2021-2026) & (k units) Table 62. North America Lyophilized IVIG Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Lyophilized IVIG Sales by Application (2021-2026) & (k units) Table 64. Europe Lyophilized IVIG Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Lyophilized IVIG Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Lyophilized IVIG Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Lyophilized IVIG Sales by Application (2021-2026) & (k units) Table 68. Latin America Lyophilized IVIG Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Lyophilized IVIG Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Lyophilized IVIG Sales by Application (2021-2026) & (US$ Million) Table 71. Biotest Company Information Table 72. Biotest Business Overview Table 73. Biotest Lyophilized IVIG Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Biotest Lyophilized IVIG Product Portfolio Table 75. Biotest Recent Development Table 76. BPL Company Information Table 77. BPL Business Overview Table 78. BPL Lyophilized IVIG Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. BPL Lyophilized IVIG Product Portfolio Table 80. BPL Recent Development Table 81. CBPO Company Information Table 82. CBPO Business Overview Table 83. CBPO Lyophilized IVIG Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. CBPO Lyophilized IVIG Product Portfolio Table 85. CBPO Recent Development Table 86. CNBG Company Information Table 87. CNBG Business Overview Table 88. CNBG Lyophilized IVIG Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. CNBG Lyophilized IVIG Product Portfolio Table 90. CNBG Recent Development Table 91. CSL Company Information Table 92. CSL Business Overview Table 93. CSL Lyophilized IVIG Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. CSL Lyophilized IVIG Product Portfolio Table 95. CSL Recent Development Table 96. Grifols Company Information Table 97. Grifols Business Overview Table 98. Grifols Lyophilized IVIG Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Grifols Lyophilized IVIG Product Portfolio Table 100. Grifols Recent Development Table 101. Kedrion Company Information Table 102. Kedrion Business Overview Table 103. Kedrion Lyophilized IVIG Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Kedrion Lyophilized IVIG Product Portfolio Table 105. Kedrion Recent Development Table 106. LFB Group Company Information Table 107. LFB Group Business Overview Table 108. LFB Group Lyophilized IVIG Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. LFB Group Lyophilized IVIG Product Portfolio Table 110. LFB Group Recent Development Table 111. Octapharma Company Information Table 112. Octapharma Business Overview Table 113. Octapharma Lyophilized IVIG Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Octapharma Lyophilized IVIG Product Portfolio Table 115. Octapharma Recent Development Table 116. Hualan Bio Company Information Table 117. Hualan Bio Business Overview Table 118. Hualan Bio Lyophilized IVIG Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Hualan Bio Lyophilized IVIG Product Portfolio Table 120. Hualan Bio Recent Development Table 121. Shanghai RAAS Company Information Table 122. Shanghai RAAS Business Overview Table 123. Shanghai RAAS Lyophilized IVIG Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Shanghai RAAS Lyophilized IVIG Product Portfolio Table 125. Shanghai RAAS Recent Development Table 126. Sichuan Yuanda Shuyang Company Information Table 127. Sichuan Yuanda Shuyang Business Overview Table 128. Sichuan Yuanda Shuyang Lyophilized IVIG Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Sichuan Yuanda Shuyang Lyophilized IVIG Product Portfolio Table 130. Sichuan Yuanda Shuyang Recent Development Table 131. Takeda Company Information Table 132. Takeda Business Overview Table 133. Takeda Lyophilized IVIG Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. Takeda Lyophilized IVIG Product Portfolio Table 135. Takeda Recent Development Table 136. North America Lyophilized IVIG Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. North America Lyophilized IVIG Sales by Country (2021-2026) & (k units) Table 138. North America Lyophilized IVIG Sales Market Share by Country (2021-2026) Table 139. North America Lyophilized IVIG Sales Forecast by Country (2027-2032) & (k units) Table 140. North America Lyophilized IVIG Sales Market Share Forecast by Country (2027-2032) Table 141. North America Lyophilized IVIG Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America Lyophilized IVIG Market Size by Country (2021-2026) & (US$ Million) Table 143. North America Lyophilized IVIG Market Share by Country (2021-2026) Table 144. North America Lyophilized IVIG Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America Lyophilized IVIG Market Share Forecast by Country (2027-2032) Table 146. Europe Lyophilized IVIG Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Europe Lyophilized IVIG Sales by Country (2021-2026) & (k units) Table 148. Europe Lyophilized IVIG Sales Market Share by Country (2021-2026) Table 149. Europe Lyophilized IVIG Sales Forecast by Country (2027-2032) & (k units) Table 150. Europe Lyophilized IVIG Sales Market Share Forecast by Country (2027-2032) Table 151. Europe Lyophilized IVIG Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe Lyophilized IVIG Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe Lyophilized IVIG Market Share by Country (2021-2026) Table 154. Europe Lyophilized IVIG Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe Lyophilized IVIG Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Lyophilized IVIG Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Lyophilized IVIG Sales by Country (2021-2026) & (k units) Table 158. Asia-Pacific Lyophilized IVIG Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific Lyophilized IVIG Sales Forecast by Country (2027-2032) & (k units) Table 160. Asia-Pacific Lyophilized IVIG Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Lyophilized IVIG Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Lyophilized IVIG Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific Lyophilized IVIG Market Share by Country (2021-2026) Table 164. Asia-Pacific Lyophilized IVIG Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific Lyophilized IVIG Market Share Forecast by Country (2027-2032) Table 166. Latin America Lyophilized IVIG Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 167. Latin America Lyophilized IVIG Sales by Country (2021-2026) & (k units) Table 168. Latin America Lyophilized IVIG Sales Market Share by Country (2021-2026) Table 169. Latin America Lyophilized IVIG Sales Forecast by Country (2027-2032) & (k units) Table 170. Latin America Lyophilized IVIG Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America Lyophilized IVIG Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America Lyophilized IVIG Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America Lyophilized IVIG Market Share by Country (2021-2026) Table 174. Latin America Lyophilized IVIG Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America Lyophilized IVIG Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Lyophilized IVIG Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Lyophilized IVIG Sales by Country (2021-2026) & (k units) Table 178. Middle East and Africa Lyophilized IVIG Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa Lyophilized IVIG Sales Forecast by Country (2027-2032) & (k units) Table 180. Middle East and Africa Lyophilized IVIG Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Lyophilized IVIG Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Lyophilized IVIG Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa Lyophilized IVIG Market Share by Country (2021-2026) Table 184. Middle East and Africa Lyophilized IVIG Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa Lyophilized IVIG Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Lyophilized IVIG Distributors List Table 189. Lyophilized IVIG Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Lyophilized IVIG Image Figure 2. Global Lyophilized IVIG Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lyophilized IVIG Market Size (2021-2032) & (US$ Million) Figure 4. Global Lyophilized IVIG Sales (2021-2032) & (k units) Figure 5. 2.5g Image Figure 6. Global 2.5g Sales YoY Growth (2021-2032) & (k units) Figure 7. 1.25g Image Figure 8. Global 1.25g Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Lyophilized IVIG Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Lyophilized IVIG Market Share by Type 2025 VS 2032 Figure 11. North America Lyophilized IVIG Sales Market Share in Volume by Type in 2025 Figure 12. North America Lyophilized IVIG Sales Market Share in Value by Type in 2025 Figure 13. Europe Lyophilized IVIG Sales Market Share in Volume by Type in 2025 Figure 14. Europe Lyophilized IVIG Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Lyophilized IVIG Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Lyophilized IVIG Sales Market Share in Value by Type in 2025 Figure 17. Latin America Lyophilized IVIG Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Lyophilized IVIG Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Lyophilized IVIG Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Lyophilized IVIG Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Lyophilized IVIG Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Autoimmune Disease Image Figure 24. Global Autoimmune Disease Sales YoY Growth (2021-2032) & (k units) Figure 25. Immunodeficiency Image Figure 26. Global Immunodeficiency Sales YoY Growth (2021-2032) & (k units) Figure 27. Acute Infection Image Figure 28. Global Acute Infection Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Lyophilized IVIG Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Lyophilized IVIG Market Share by Application 2025 VS 2032 Figure 31. North America Lyophilized IVIG Sales Market Share in Volume by Application in 2025 Figure 32. North America Lyophilized IVIG Sales Market Share in Value by Application in 2025 Figure 33. Europe Lyophilized IVIG Sales Market Share in Volume by Application in 2025 Figure 34. Europe Lyophilized IVIG Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Lyophilized IVIG Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Lyophilized IVIG Sales Market Share in Value by Application in 2025 Figure 37. Latin America Lyophilized IVIG Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Lyophilized IVIG Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Lyophilized IVIG Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Lyophilized IVIG Sales Market Share in Value by Application in 2025 Figure 41. North America Lyophilized IVIG Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Lyophilized IVIG Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Lyophilized IVIG Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Lyophilized IVIG Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Lyophilized IVIG Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Lyophilized IVIG Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Lyophilized IVIG Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Lyophilized IVIG Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Lyophilized IVIG Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Lyophilized IVIG Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Lyophilized IVIG Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Lyophilized IVIG Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Lyophilized IVIG Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Lyophilized IVIG Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Lyophilized IVIG Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Lyophilized IVIG Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Lyophilized IVIG Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Lyophilized IVIG Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Lyophilized IVIG Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Lyophilized IVIG Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Lyophilized IVIG Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Lyophilized IVIG Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 2.5g
  • 1.25g
Applications
  • Autoimmune Disease
  • Immunodeficiency
  • Acute Infection
Companies covered
  • Biotest
  • BPL
  • CBPO
  • CNBG
  • CSL
  • Grifols
  • Kedrion
  • LFB Group
  • Octapharma
  • Hualan Bio
  • Shanghai RAAS
  • Sichuan Yuanda Shuyang
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Lyophilized IVIG Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Lyophilized IVIG Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Lyophilized IVIG Market by Type
  6. 1.3.1 2.5g
  7. 1.3.2 1.25g
  8. 1.4 Global Lyophilized IVIG Market Size by Type
  9. 1.4.1 Global Lyophilized IVIG Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Lyophilized IVIG Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Lyophilized IVIG Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Lyophilized IVIG Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Lyophilized IVIG Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Lyophilized IVIG Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Lyophilized IVIG Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Lyophilized IVIG Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Lyophilized IVIG Industry Trends
  2. 2.2 Lyophilized IVIG Industry Drivers
  3. 2.3 Lyophilized IVIG Industry Opportunities and Challenges
  4. 2.4 Lyophilized IVIG Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Lyophilized IVIG Revenue (2021-2026)
  2. 3.2 Global Top Players by Lyophilized IVIG Sales (2021-2026)
  3. 3.3 Global Top Players by Lyophilized IVIG Price (2021-2026)
  4. 3.4 Global Lyophilized IVIG Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Lyophilized IVIG Major Company Production Sites & Headquarters
  6. 3.6 Global Lyophilized IVIG Company, Product Type & Application
  7. 3.7 Global Lyophilized IVIG Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Lyophilized IVIG Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Lyophilized IVIG Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Lyophilized IVIG Tier 1, Tier 2, and Tier 3
4 Lyophilized IVIG Regional Status and Outlook
  1. 4.1 Global Lyophilized IVIG Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Lyophilized IVIG Historic Market Size by Region
  3. 4.2.1 Global Lyophilized IVIG Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Lyophilized IVIG Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Lyophilized IVIG Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Lyophilized IVIG Forecasted Market Size by Region
  7. 4.3.1 Global Lyophilized IVIG Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Lyophilized IVIG Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Lyophilized IVIG Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Lyophilized IVIG by Application
  1. 5.1 Lyophilized IVIG Market by Application
  2. 5.1.1 Autoimmune Disease
  3. 5.1.2 Immunodeficiency
  4. 5.1.3 Acute Infection
  5. 5.2 Global Lyophilized IVIG Market Size by Application
  6. 5.2.1 Global Lyophilized IVIG Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Lyophilized IVIG Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Lyophilized IVIG Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Lyophilized IVIG Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Lyophilized IVIG Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Lyophilized IVIG Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Lyophilized IVIG Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Lyophilized IVIG Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Biotest
  2. 6.1.1 Biotest Company Information
  3. 6.1.2 Biotest Business Overview
  4. 6.1.3 Biotest Lyophilized IVIG Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Biotest Lyophilized IVIG Product Portfolio
  6. 6.1.5 Biotest Recent Developments
  7. 6.2 BPL
  8. 6.2.1 BPL Company Information
  9. 6.2.2 BPL Business Overview
  10. 6.2.3 BPL Lyophilized IVIG Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 BPL Lyophilized IVIG Product Portfolio
  12. 6.2.5 BPL Recent Developments
  13. 6.3 CBPO
  14. 6.3.1 CBPO Company Information
  15. 6.3.2 CBPO Business Overview
  16. 6.3.3 CBPO Lyophilized IVIG Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 CBPO Lyophilized IVIG Product Portfolio
  18. 6.3.5 CBPO Recent Developments
  19. 6.4 CNBG
  20. 6.4.1 CNBG Company Information
  21. 6.4.2 CNBG Business Overview
  22. 6.4.3 CNBG Lyophilized IVIG Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 CNBG Lyophilized IVIG Product Portfolio
  24. 6.4.5 CNBG Recent Developments
  25. 6.5 CSL
  26. 6.5.1 CSL Company Information
  27. 6.5.2 CSL Business Overview
  28. 6.5.3 CSL Lyophilized IVIG Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 CSL Lyophilized IVIG Product Portfolio
  30. 6.5.5 CSL Recent Developments
  31. 6.6 Grifols
  32. 6.6.1 Grifols Company Information
  33. 6.6.2 Grifols Business Overview
  34. 6.6.3 Grifols Lyophilized IVIG Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Grifols Lyophilized IVIG Product Portfolio
  36. 6.6.5 Grifols Recent Developments
  37. 6.7 Kedrion
  38. 6.7.1 Kedrion Company Information
  39. 6.7.2 Kedrion Business Overview
  40. 6.7.3 Kedrion Lyophilized IVIG Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Kedrion Lyophilized IVIG Product Portfolio
  42. 6.7.5 Kedrion Recent Developments
  43. 6.8 LFB Group
  44. 6.8.1 LFB Group Company Information
  45. 6.8.2 LFB Group Business Overview
  46. 6.8.3 LFB Group Lyophilized IVIG Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 LFB Group Lyophilized IVIG Product Portfolio
  48. 6.8.5 LFB Group Recent Developments
  49. 6.9 Octapharma
  50. 6.9.1 Octapharma Company Information
  51. 6.9.2 Octapharma Business Overview
  52. 6.9.3 Octapharma Lyophilized IVIG Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Octapharma Lyophilized IVIG Product Portfolio
  54. 6.9.5 Octapharma Recent Developments
  55. 6.10 Hualan Bio
  56. 6.10.1 Hualan Bio Company Information
  57. 6.10.2 Hualan Bio Business Overview
  58. 6.10.3 Hualan Bio Lyophilized IVIG Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Hualan Bio Lyophilized IVIG Product Portfolio
  60. 6.10.5 Hualan Bio Recent Developments
  61. 6.11 Shanghai RAAS
  62. 6.11.1 Shanghai RAAS Company Information
  63. 6.11.2 Shanghai RAAS Business Overview
  64. 6.11.3 Shanghai RAAS Lyophilized IVIG Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Shanghai RAAS Lyophilized IVIG Product Portfolio
  66. 6.11.5 Shanghai RAAS Recent Developments
  67. 6.12 Sichuan Yuanda Shuyang
  68. 6.12.1 Sichuan Yuanda Shuyang Company Information
  69. 6.12.2 Sichuan Yuanda Shuyang Business Overview
  70. 6.12.3 Sichuan Yuanda Shuyang Lyophilized IVIG Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Sichuan Yuanda Shuyang Lyophilized IVIG Product Portfolio
  72. 6.12.5 Sichuan Yuanda Shuyang Recent Developments
  73. 6.13 Takeda
  74. 6.13.1 Takeda Company Information
  75. 6.13.2 Takeda Business Overview
  76. 6.13.3 Takeda Lyophilized IVIG Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Takeda Lyophilized IVIG Product Portfolio
  78. 6.13.5 Takeda Recent Developments
7 North America by Country
  1. 7.1 North America Lyophilized IVIG Sales by Country
  2. 7.1.1 North America Lyophilized IVIG Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Lyophilized IVIG Sales by Country (2021-2026)
  4. 7.1.3 North America Lyophilized IVIG Sales Forecast by Country (2027-2032)
  5. 7.2 North America Lyophilized IVIG Market Size by Country
  6. 7.2.1 North America Lyophilized IVIG Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Lyophilized IVIG Market Size by Country (2021-2026)
  8. 7.2.3 North America Lyophilized IVIG Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Lyophilized IVIG Sales by Country
  2. 8.1.1 Europe Lyophilized IVIG Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Lyophilized IVIG Sales by Country (2021-2026)
  4. 8.1.3 Europe Lyophilized IVIG Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Lyophilized IVIG Market Size by Country
  6. 8.2.1 Europe Lyophilized IVIG Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Lyophilized IVIG Market Size by Country (2021-2026)
  8. 8.2.3 Europe Lyophilized IVIG Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Lyophilized IVIG Sales by Country
  2. 9.1.1 Asia-Pacific Lyophilized IVIG Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Lyophilized IVIG Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Lyophilized IVIG Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Lyophilized IVIG Market Size by Country
  6. 9.2.1 Asia-Pacific Lyophilized IVIG Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Lyophilized IVIG Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Lyophilized IVIG Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Lyophilized IVIG Sales by Country
  2. 10.1.1 South America Lyophilized IVIG Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Lyophilized IVIG Sales by Country (2021-2026)
  4. 10.1.3 South America Lyophilized IVIG Sales Forecast by Country (2027-2032)
  5. 10.2 South America Lyophilized IVIG Market Size by Country
  6. 10.2.1 South America Lyophilized IVIG Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Lyophilized IVIG Market Size by Country (2021-2026)
  8. 10.2.3 South America Lyophilized IVIG Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Lyophilized IVIG Sales by Country
  2. 11.1.1 Middle East and Africa Lyophilized IVIG Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Lyophilized IVIG Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Lyophilized IVIG Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Lyophilized IVIG Market Size by Country
  6. 11.2.1 Middle East and Africa Lyophilized IVIG Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Lyophilized IVIG Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Lyophilized IVIG Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Lyophilized IVIG Value Chain Analysis
  2. 12.1.1 Lyophilized IVIG Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Lyophilized IVIG Production Mode & Process
  7. 12.2 Lyophilized IVIG Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Lyophilized IVIG Distributors
  10. 12.2.3 Lyophilized IVIG Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst